| 000 | 01613 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513050553.0 | ||
| 264 | 0 | _c19950407 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRusso, D | |
| 245 | 0 | 0 |
_aMDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine. _h[electronic resource] |
| 260 |
_bLeukemia _cMar 1995 |
||
| 300 |
_a513-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xphysiology |
| 650 | 0 | 4 |
_aAdenocarcinoma _xpathology |
| 650 | 0 | 4 |
_aColonic Neoplasms _xpathology |
| 650 | 0 | 4 |
_aCyclosporins _xpharmacology |
| 650 | 0 | 4 |
_aDaunorubicin _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 |
_aHarringtonines _xpharmacology |
| 650 | 0 | 4 | _aHomoharringtonine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia-Lymphoma, Adult T-Cell _xpathology |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xphysiology |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 650 | 0 | 4 |
_aVinblastine _xpharmacology |
| 700 | 1 | _aMichelutti, A | |
| 700 | 1 | _aMelli, C | |
| 700 | 1 | _aDamiani, D | |
| 700 | 1 | _aMichieli, M G | |
| 700 | 1 | _aCandoni, A | |
| 700 | 1 | _aZhou, D C | |
| 700 | 1 | _aMarie, J P | |
| 700 | 1 | _aZittoun, R | |
| 700 | 1 | _aBaccarani, M | |
| 773 | 0 |
_tLeukemia _gvol. 9 _gno. 3 _gp. 513-6 |
|
| 999 |
_c7884383 _d7884383 |
||